Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Iodine-based x-ray attenuation exploits physical principles related to atomic number and electron shell structure. Its quantifiable relationship with image intensity underpins its central role as a clinical contrast agent but also imposes limitations based on dose requirements and potential side effects. Advances continue around optimizing molecular design for improved safety and efficacy while maintaining robust quantitative performance across modern imaging platforms.
Enhancement of X-ray attenuation via photoelectric absorption by iodine atoms, maximized near the K-edge energy (33.2 keV).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on X-ray Attenuation (via Iodine Content) (N/A).